Business
Result of Placing and Subscription
Result of Placing and Subscription.
About this update from Rua Life Sciences Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (\"UK MAR\"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION, AS PERMITTED BY UK MAR. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.\n \n \n \n1 December 2023\nRUA LIFE SCIENCES PLC\n(\"RUA\" or the \"Company\")\n \nResult of Placing and Subscription\n \n \nFurther to the announcement made on 30 November 2023 regarding a proposed placing, subscription and retail offer (the \"Launch Announcement\"), RUA Life Sciences plc (AIM: RUA.L) is pleased to announce that, it has conditionally raised gross proceeds of approximately £4.0 million (before expenses) under the Placing. In total, 36,363,636 Placing Shares have been conditionally placed at the Issue Price of 11 pence per share.\n \nIn addition, the Directors of the Company have confirmed their intention to subscribe for an additional 727,272 Subscription Shares, raising a further £80,000. As the Company is currently in a close period under MAR until the publication of its interim results for the period ended 30 September 2023 (the \"Results\"), the Directors are not permitted to enter into a subscription agreement until after publication of these results (and subject to each not being in possession of any other unpublished price sensitive information at such time). Whilst it is expected that the Results will be published prior to the expected date of Admission, in the event that the Directors are unable to s...